Effect of hydroxypropyl-beta-cyclodextrin on the solubility, stability and in-vitro release of ciprofloxacin for ocular drug delivery
- PMID: 22876616
Effect of hydroxypropyl-beta-cyclodextrin on the solubility, stability and in-vitro release of ciprofloxacin for ocular drug delivery
Abstract
Eye drops in the form of an aqueous solution with a lower viscosity are preferred for local administrations in ophthalmology. In ophthalmic formulations, cyclodextrins (CDs) are frequently used in recent years in order to increase water solubility, stability and bioavailability of an active substance and decrease an irritation to the eye. The scope of the present study was to investigate the influence of hydroxypropyl-beta-cyclodextrin (HPCD) on the solubility, stability and in vitro release of ciprofloxacin (CIP). According to the phase solubility studies, A(L) type solubility curve was obtained. HPCD improved the solubility of CIP 3 times at pH 5.5 and 2 times at pH 7.4. The two month stability studies indicated that CIP was more stable at pH 5.5 than at pH 7.4 and the stability of CIP was significantly increased by HPCD. The stability constant of the HPCD:CIP complex was increased further by a-ddition of 0.1% (w/v) polymer (HPMC and PVP) to the aqueous medium including HPCD. Stability constant of solutions prepared in an ultrasonic water bath was higher than solutions prepared by heating in an autoclave. The results indicated that the CIP:HPCD complex increased in vitro release of CIP and the addition of polymer promoted this increase even more.
Similar articles
-
Thermosensitive and pH induced in situ ophthalmic gelling system for ciprofloxacin hydrochloride: hydroxypropyl-beta-cyclodextrin complex.Acta Pol Pharm. 2012 Nov-Dec;69(6):1137-47. Acta Pol Pharm. 2012. PMID: 23285675
-
Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.Eur J Pharm Biopharm. 2008 Sep;70(1):260-9. doi: 10.1016/j.ejpb.2008.04.010. Epub 2008 Apr 24. Eur J Pharm Biopharm. 2008. PMID: 18590953
-
Development of an ophthalmic formulation containing ciprofloxacin-hydroxypropyl-b-cyclodextrin complex.Boll Chim Farm. 2003 Jun;142(5):214-9. Boll Chim Farm. 2003. PMID: 14526654
-
Hydroxypropyl methylcellulose: Physicochemical properties and ocular drug delivery formulations.Eur J Pharm Sci. 2021 Apr 1;159:105736. doi: 10.1016/j.ejps.2021.105736. Epub 2021 Jan 28. Eur J Pharm Sci. 2021. PMID: 33516807 Review.
-
Role of cyclodextrins in ophthalmics.Curr Drug Deliv. 2004 Oct;1(4):351-60. doi: 10.2174/1567201043334623. Curr Drug Deliv. 2004. PMID: 16305397 Review.
Cited by
-
Effect of Cyclodextrins on Morphology and Barrier Characteristics of Isolated Rabbit Corneas.AAPS PharmSciTech. 2015 Oct;16(5):1220-6. doi: 10.1208/s12249-015-0315-z. Epub 2015 Mar 14. AAPS PharmSciTech. 2015. PMID: 25771740 Free PMC article.
-
Nanoliposome-Encapsulated Brinzolamide-hydropropyl-β-cyclodextrin Inclusion Complex: A Potential Therapeutic Ocular Drug-Delivery System.Front Pharmacol. 2018 Feb 13;9:91. doi: 10.3389/fphar.2018.00091. eCollection 2018. Front Pharmacol. 2018. PMID: 29487529 Free PMC article.
-
Carrier Systems for Advanced Drug Delivery: Improving Drug Solubility/Bioavailability and Administration Routes.Pharmaceutics. 2024 Jun 25;16(7):852. doi: 10.3390/pharmaceutics16070852. Pharmaceutics. 2024. PMID: 39065549 Free PMC article. Review.
-
Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems-A Pharmaceutical Perspective.Pharmaceutics. 2022 Jun 30;14(7):1389. doi: 10.3390/pharmaceutics14071389. Pharmaceutics. 2022. PMID: 35890285 Free PMC article. Review.
-
Principles of pharmacology in the eye.Br J Pharmacol. 2017 Dec;174(23):4205-4223. doi: 10.1111/bph.14024. Epub 2017 Oct 10. Br J Pharmacol. 2017. PMID: 28865239 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources